Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharmaceutical R. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel patent CN105315212A enables efficient Tolvaptan production. Reduces steps, avoids heavy metals. Reliable supply chain partner for pharma intermediates.
Patent CN109305940B reveals a 3-step synthesis for Roxadustat intermediates. Discover cost-effective, scalable manufacturing solutions for high-purity pharmaceutical intermediates.
Patent CN113336792A reveals a novel Lewis acid-catalyzed synthesis for cyclic phosphonates, offering superior stereoselectivity and yield for pharmaceutical manufacturing.
Patent CN116621745A reveals a metal-free synthesis for aryl sulfides. Discover cost-effective, high-purity manufacturing solutions for pharmaceutical intermediates.
Efficient semi-synthesis of deserpidine from reserpine lactone via selective demethylation. Reduces costs and improves supply chain reliability for antihypertensive APIs.
Patent CN119874536A reveals high-purity MOCA purification. Achieve ≥99.0% purity and ≥90% yield for reliable polyurethane curing agent supply chains.
Patent CN102219792A details a green, high-yield synthesis of prasugrel intermediates via Grignard reaction and thermal decomposition, offering significant cost reduction.
Novel synthesis route for angiotensin II receptor antagonist intermediates offering improved yield and purity for pharmaceutical manufacturing.
Patent CN106434611A details a high-yield enzymatic route for L-Ornithine, offering superior purity and supply chain stability for nutritional and pharmaceutical applications.
Advanced enzymatic resolution process for high-purity pharmaceutical intermediates. Reduces cost and improves supply chain reliability for global buyers.
Discover a cost-effective, non-cyanide route for high-purity polymethoxy phenylacetic acid. Ideal for API synthesis like CA4 and Pterostilbene precursors.
Patent CN110981676A discloses a metal-free visible light method for beta-ketosulfones. Offers cost reduction and green manufacturing for pharmaceutical intermediates.
Patent CN1205196C reveals a novel C(10) selective acylation method for 10-DAB. Discover cost-effective taxane intermediate manufacturing and supply chain advantages.
Patent CN105399728B reveals high-yield R-lansoprazole production. Enhances supply chain reliability and reduces manufacturing costs for pharmaceutical partners globally.
Novel metal-free decarboxylative ketonization method offers cost-effective, scalable production of high-purity pharmaceutical intermediates with green chemistry advantages.
Patent CN110407846A reveals high-purity 5-ISMN synthesis. Enhances supply chain reliability and reduces manufacturing costs for pharmaceutical intermediates.
Patent CN100338078C reveals high-purity phosphorodiamidite production reducing diester impurities for reliable oligonucleotide intermediate supply chains.
Patent CN102190642B reveals a novel Prins reaction route for Corey lactone. This method offers significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN107759619B reveals a mild organocatalytic route for dihydropyrano-thiazoles, offering high yields and stereocontrol for reliable pharmaceutical intermediate supply chains.
Patent CN102336676A reveals a novel arylmethyl protection strategy for Dopexamine Hydrochloride, offering mild deprotection conditions and superior supply chain reliability for pharmaceutical manufacturers.